| NCT ID | NCT06445231 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nantes University Hospital |
| Condition | Heart Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,050 participants |
| Start Date | 2024-10-02 |
| Primary Completion | 2028-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,050 participants in total. It began in 2024-10-02 with a primary completion date of 2028-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study seeks to explore the implementation characteristics (acceptability, appropriateness, feasibility, adoption, fidelity, penetration, implementation cost and sustainability) of systematic echocardiography in nursing homes and its impact on rates of heart failure flare-up and unscheduled hospitalization at 12 months among included nursing homes.
Eligibility Criteria
Inclusion Criteria : Nursing homes residents with a life-expectancy estimated \> 1 year, and able to participate to the study, giving an oral consent Exclusion Criteria : * no accessible to echocardiography * closed unit (severe Alzheimer disease…) * recent contagious disease such Covid (\<15 days) * no consent to participate * no social security number
Contact & Investigator
Thierry LE TOURNEAU, PU-PH
PRINCIPAL INVESTIGATOR
Nantes University Hospital
Frequently Asked Questions
Who can join the NCT06445231 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Heart Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06445231 currently recruiting?
Yes, NCT06445231 is actively recruiting participants. Contact the research team at thierry.letourneau@chu-nantes.fr for enrollment information.
Where is the NCT06445231 trial being conducted?
This trial is being conducted at Nantes, France.
Who is sponsoring the NCT06445231 clinical trial?
NCT06445231 is sponsored by Nantes University Hospital. The principal investigator is Thierry LE TOURNEAU, PU-PH at Nantes University Hospital. The trial plans to enroll 1,050 participants.